Abide Therapeutics and Merck, referred to as MSD outside the US and Canada, have collaborated to develop new therapies for type 2 diabetes and metabolic diseases. The collaboration will focus on the discovery, development and ...
Tags: Abide Therapeutics, Medicine
Insulet Corporation and Eli Lilly and Company have entered into a collaboration under which Insulet will develop a new version of the OmniPod insulin pump designed to deliver Humulin R U-500 insulin. R U-500 insulin is a regular U-500 ...
Tags: Insulet, Eli Lilly, Insulin Pump
The US food and drug administration (FDA) has approved Janssen's Invokana (canagliflozin) for the treatment of adults with type 2 diabetes. Invokana is the oral, once-daily medication available in the US demonstrating improved glycemic ...
Boehringer Ingelheim and Eli Lilly and Company have announced the submission of new drug application (NDA) to FDA for an investigational type 2 diabetes mellitus (T2D) treatment, empagliflozin. Empagliflozin belongs to sodium glucose ...
Tags: diabetes therapy, drug application, drug
CMS Medical, a distributor and manufacturer of minimally-invasive medical products in Brazil, has entered into a collaboration agreement with GI Dynamics. Under the deal, CMS will distribute GI Dynamics' EndoBarrier therapy in Brazil, ...
Sleep problems keeping you up at night? Exercise, no matter the level or time of day, might help, according to a poll by the National Sleep Foundation released this week. It found that people who exercise, whether light or vigorous, early ...
Tags: Insomnia, health problem, sleep
If you take Byetta or Januvia to control your blood sugar levels, you might have a small, but increased risk for a condition marked by stomach pain and nausea. Not only are the drugs more expensive and no more effective than our Best Buy ...
Tags: Byetta, Januvia, blood sugar levels, diabetes
CeQur has reported its PaQ insulin delivery device initial study data at the 6th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD) in Paris, France. The discreet, wearable CE-marked device, which comprises ...
Tags: CeQur, PaQ insulin delivery device, insulin infuser reservoir
The results were based on a study on more than 30,000 people. It found that the general population’s exposure to the chemical was too low to have any toxic effects. Experts have claimed that range of human disorders including ...
Mylan Pharmaceuticals, a subsidiary of global pharmaceutical company Mylan, has launched Fenofibrate Capsules USP, 43 mg and 130 mg. Fenofibrate Capsules, which are generic equivalent to Lupin Atlantis Holdings' Antara Capsules, are ...
Tags: Mylan Pharmaceuticals, Fenofibrate Capsules, pharmaceutical company
The US Food and Drug Administration (FDA) has accepted to review Sanofi's new drug application (NDA) of lixisenatide, a once-daily a glucagon-like peptide-1 receptor agonist (GLP-1 RA), for the treatment of adults with type 2 diabetes ...
Novo Nordisk has received an approval of the price from Japan's Central Social Insurance Medical Council (Chuikyo), the advisory committee to the Minister of Health, Labour and Welfare, and is set to launch Tresiba (insulin degludec) in ...
Tags: diabetes therapy, Medical, Novo Nordisk
The USFDA has issued final approval to manufacture and market Aurobindo Pharma's diabetes drugs, Pioglitazone tablets and Pioglitazone Hydrochloride + Metformin Hydrochloride tablets. Pioglitazone Tablets USP 15mg, 30mg & 45mg and ...
Tags: USFDA, Aurobindo Pharma, diabetes drugs
UK-based pharmaceutical company Bristol-Myers Squibb and AstraZeneca have announced that the National Institute for Health and Clinical Excellence (NICE) in the UK has issued an Appraisal Consultation Document (ACD) for its first-in-class, ...
Tags: pharmaceutical company, Bristol-Myers Squibb, AstraZeneca, NICE
Takeda Pharmaceutical has received FDA approval for three new type 2 diabetes therapies Nesina (alogliptin) and fixed-dose combinations Oseni (alogliptin and pioglitazone) and Kazano (alogliptin and metformin HCl). Takeda expects to ...
Tags: FDA, diabetes therapies, Pharmaceuticals